Related Experiment Video
Updated: Aug 7, 2025

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
[The study of a key molecule Caspase-1 of inflammasome in hepatitis B virus-related diseases]
1Beijing Youan Hospital, Capital Medical University & Beijing Institute of Hepatology, Beijing 100069, China.
Insights
Aspartate-specific cysteine protease (Caspase)-1 plays a key role in hepatitis B virus (HBV)-related liver diseases. Its expression and activity differ significantly across conditions like chronic hepatitis B, cirrhosis, hepatocellular carcinoma, and acute-on-chronic liver failure.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Context:
- Hepatitis B virus (HBV) infection is a global health concern, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma.
- Inflammasomes, particularly involving Caspase-1, are implicated in inflammatory responses and disease pathogenesis.
- Understanding the role of Caspase-1 in HBV-related liver conditions is crucial for developing targeted therapies.
Purpose:
- To investigate the expression, activity, and role of aspartate-specific cysteine protease (Caspase)-1 in various hepatitis B virus (HBV)-related liver diseases.
- To compare Caspase-1 levels and activity in patients with chronic hepatitis B (CHB), liver cirrhosis (LC), hepatocellular carcinoma (HCC), and acute-on-chronic liver failure (ACLF) against healthy controls.
Summary:
- Real-time PCR revealed altered Caspase-1 mRNA levels in CHB, LC, HCC (downregulated), and ACLF (upregulated) patients compared to controls.
- Immunofluorescence showed varied Caspase-1 protein levels, with elevation in ACLF and reduction in HCC and LC.
- Caspase-1 activity was slightly increased in CHB, LC, and HCC tissues but significantly reduced in ACLF. Serum Caspase-1 levels were universally lower in HBV patients, with the lowest levels observed in ACLF.
Impact:
- Caspase-1 exhibits distinct expression patterns and activity profiles in different HBV-related liver diseases, particularly highlighting its unique role in ACLF.
- These findings suggest Caspase-1 as a potential biomarker for disease severity and progression in HBV infection.
- The study provides insights into the inflammatory mechanisms underlying HBV pathogenesis, paving the way for novel therapeutic strategies targeting inflammasomes.
Abstract:
Objective: To investigate the expression and role of asparte-specific cysteine protease (Caspase)-1, inflammasomes key molecule, in hepatitis B virus (HBV)-related diseases. Methods: HBV-related liver disease patients' serum (438 cases) and liver tissue (82 cases) samples were collected from Beijing You'an Hospital affiliated with Capital Medical University. The mRNA expression level of caspase-1 in liver tissue was detected by real-time fluorescence quantitative PCR (qRT-PCR). The protein expression level of Caspase-1 in liver tissue was detected by the immunofluorescence method. The activity of Caspase-1 was detected using the Caspase-1 colorimetric assay kit. The level of Caspase-1 in the serum was detected by an ELISA kit. Results: The results of qRT-PCR showed that the mRNA level of Caspase-1 was downregulated in patients with chronic hepatitis B (CHB), cirrhosis (LC), and hepatocellular carcinoma (HCC), while up-regulated in patients with acute-on-chronic liver failure (ACLF) (P<0.01) compared with normal subjects. Immunofluorescence assays showed that Caspase-1 protein levels were elevated in ACLF patients, decreased in HCC and LC patients, and slightly elevated in CHB patients. The activity of Caspase-1 was slightly higher in liver tissue from CHB, LC, and HCC patients than in the normal control group, and there was no statistically significant difference between the groups. Additionally, compared with the control group, Caspase-1 activity was significantly reduced in the ACLF group (P<0.01). Serum Caspase-1 levels were significantly lower in patients with CHB, ACLF, LC, and HCC than in normal subjects, and serum Caspase-1 levels were lowest in patients with ACLF (P<0.001). Conclusion: Caspase-1, a key molecule of inflammasomes, plays an important role in HBV-related diseases and has significant differences, showing distinct features for ACLF than other HBV-related diseases.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

